207 related articles for article (PubMed ID: 36407985)
1. Patent foramen ovale closure vs. medical therapy alone after cryptogenic stroke in China: A cost-effectiveness analysis.
Wei N; Liu B; Ma M; Zhang X; Zhang W; Hou F; Liu F; Yu X
Front Public Health; 2022; 10():1016854. PubMed ID: 36407985
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective.
Hildick-Smith D; Turner M; Shaw L; Nakum M; Hartaigh BÓ; Evans RM; Rhodes JF; Sondergaard L; Kasner SE
J Med Econ; 2019 Feb; 22(2):131-139. PubMed ID: 30424680
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective.
Volpi JJ; Ridge JR; Nakum M; Rhodes JF; Søndergaard L; Kasner SE
J Med Econ; 2019 Sep; 22(9):883-890. PubMed ID: 31025589
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke.
Shijoh Y; Saito S; Dai Z; Ohde S
PLoS One; 2022; 17(6):e0268690. PubMed ID: 35657973
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.
Leppert MH; Poisson SN; Carroll JD; Thaler DE; Kim CH; Orjuela KD; Ho PM; Burke JF; Campbell JD
Stroke; 2018 Jun; 49(6):1443-1450. PubMed ID: 29720435
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention.
Tirschwell DL; Turner M; Thaler D; Choulerton J; Marks D; Carroll J; MacDonald L; Smalling RW; Koullick M; Gu NY; Saver JL
J Med Econ; 2018 Jul; 21(7):656-665. PubMed ID: 29564942
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France.
Allou A; Baschet L; Sabourin C; Montalscot G; Lorgis L; Iriart X
J Cardiol; 2022 Jul; 80(1):72-79. PubMed ID: 34772575
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of Percutaneous Patent Foramen Ovale Closure Preventing Secondary Ischemic Stroke in Japan.
Inoue S; Igarashi A; Iguchi Y; Akagi T
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105884. PubMed ID: 34153592
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
Pickett CA; Villines TC; Ferguson MA; Hulten EA
Am J Cardiol; 2014 Nov; 114(10):1584-9. PubMed ID: 25248812
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.
Pickett CA; Villines TC; Resar JR; Hulten EA
Int J Cardiol; 2018 Dec; 273():74-79. PubMed ID: 30119914
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
15. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
[TBL] [Abstract][Full Text] [Related]
17. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
[TBL] [Abstract][Full Text] [Related]
18. The role of device closure of patent foramen ovale in patients with cryptogenic stroke.
Fukutomi M; Wilkins B; Søndergaard L
J Intern Med; 2020 Oct; 288(4):400-409. PubMed ID: 32812297
[TBL] [Abstract][Full Text] [Related]
19. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
Saver JL; Carroll JD; Thaler DE; Smalling RW; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2017 Sep; 377(11):1022-1032. PubMed ID: 28902590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
